Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck sues to block generic Vytorin
Bizjournals.com
Friday, March 5, 2010 - 8:27am
tags:
generics, Merck, Vytorin, lawsuits, Teva Pharmaceuticals
CSL Rises on U.S. Approval for Immune-System Therapy Hizentra
Bloomberg
Friday, March 5, 2010 - 8:25am
tags:
CSL, FDA, Hizentra
Pfizer and Bristol-Myers say their blood thinner apixaban worked better than Lovenox in study
Yahoo/AP
Friday, March 5, 2010 - 8:24am
tags:
Pfizer, Bristol-Myers Squibb, Lovenox, Apixaban
Sanofi-Aventis Looks for More China Partnerships
Seeking Alpha
Friday, March 5, 2010 - 8:22am
tags:
China, Sanofi
Justice Department's Botox Probe Costing Allergan $100M -- And There's No End in Sight
BNET Pharma
Thursday, March 4, 2010 - 6:12pm
tags:
Botox, DOJ, Allergan
Dendreon and the Prostate Cancer Battle
Minyanville
Thursday, March 4, 2010 - 6:06pm
tags:
Dendreon, Provenge, prostate cancer
Bristol-Myers: 60 drugs in testing to boost sales
Yahoo/AP
Thursday, March 4, 2010 - 6:05pm
tags:
pipelines, Bristol-Myers Squibb
A Ray Of Hope For Medivation
Forbes
Thursday, March 4, 2010 - 6:04pm
tags:
Medivation, Pfizer, Alzheimer's disease, dimebon
FDA says Takeda has agreed to rename Kadipex to avoid confusion with other drugs
Yahoo/AP
Thursday, March 4, 2010 - 11:46am
tags:
FDA, Takeda, Kapidex
OSI Pharmaceuticals Board to Consider Astellas' Unsolicited Tender Offer
Trading Markets
Thursday, March 4, 2010 - 11:42am
tags:
Astellas, OSI Pharmaceuticals, M&A
Eisai says Aricept's U.S. sales to more than halve
Reuters
Thursday, March 4, 2010 - 11:41am
tags:
Eisai, Aricept
FDA May Prosecute More Pharmaceutical Execs
Pharmalot
Thursday, March 4, 2010 - 11:40am
tags:
FDA, pharmaceutical executives
Merck Presents Positive Data
Yahoo/Zacks.com
Thursday, March 4, 2010 - 11:39am
tags:
Merck, Asmanex
La Jolla Pharma to be delisted after merger flop
Fierce Biotech
Thursday, March 4, 2010 - 9:50am
tags:
La Jolla Pharmaceutical
Merck/GTX: If a Collaboration Fails in the Forest, Does it Make a Sound?
InVivo
Thursday, March 4, 2010 - 9:48am
tags:
Merck, GTx, ostarine, licensing
Want A Good Sales Rep? Poach From Your Rival
Pharmalot
Thursday, March 4, 2010 - 9:43am
tags:
sales reps
Inspire posts smaller loss as Azasite sales rise
Yahoo/AP
Thursday, March 4, 2010 - 9:41am
tags:
Inspire, earnings, Azasite
Bristol sets baseline for profits post-Plavix
Yahoo/Reuters
Thursday, March 4, 2010 - 8:29am
tags:
Bristol-Myers Squibb, Plavix, guidance
Astellas CEO: A logical idealist
Fierce Pharma
Thursday, March 4, 2010 - 7:16am
tags:
Astellas, Pharma CEOs, Masafumi Nogimori, OSI Pharmaceuticals, M&A
Rogue Analyst Provides Questionable Fodder for Dendreon Conspiracy Theorists
BNET Pharma
Thursday, March 4, 2010 - 7:15am
tags:
Provenge, prostate cancer, Dendreon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.